EXAS

EXACT Sciences Stock Price

86.90
-3.50 (-3.87%)
Upgrade to Real-Time
Afterhours (Closed)
86.90
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
EXACT Sciences Corporation EXAS NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
-3.50 -3.87% 86.90 85.17 90.32 90.00 90.40 00:00:07
Bid Price Ask Price Spread Spread % News
86.50 92.00 5.50 5.98% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
19,041 1,545,669 $ 87.33 $ 134,979,362 1,248,605 35.2512 - 123.31
Last Trade Time Type Quantity Stock Price Currency
19:50:32 35 $ 86.90 USD

EXACT Sciences Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 13.05B 150.17M 129.88M $ 876.29M $ -119.61M -0.65 -109.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 42.40k 2.60%

more financials information »

EXACT Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EXAS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week94.00100.0085.1793.371,442,879-7.10-7.55%
1 Month92.75103.0285.1794.971,200,063-5.85-6.31%
3 Months85.36103.0277.5689.361,321,4311.541.8%
6 Months95.00103.2235.251276.141,930,025-8.10-8.53%
1 Year112.00123.3135.251285.211,940,805-25.10-22.41%
3 Years38.84123.9935.251272.721,958,96248.06123.74%
5 Years23.07123.994.6744.952,344,85763.83276.68%

EXACT Sciences Description

Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of certain types of cancer. Its core product is a noninvasive screening test, Cologuard, which analyzes stool-based DNA samples to detect the precancerous and early stages of colorectal cancer. The test includes DNA markers and a protein marker that can detect blood in the stool. Exact Sciences receives revenue from two sources: laboratory services and licensing fees. Its laboratory services revenue is generated by diagnostic services that use the Cologuard test. Exact Sciences also receives revenue from the licensing of its product rights.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.